Viatris Inc (VTRS) stock
VTRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/303% below fair value
$20.28−0.17 (-0.83%)
Close on Nov 18, 2026Market cap $23.29BP/E –Yield 2.37%
Viatris net income
Net income is the profit left for shareholders after every expense, interest and tax.
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2020 | Sep 30, 2020 | -$169.00M | – |
| Q2 FY2020 | Jun 30, 2020 | -$900.00K | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | – |
| Q3 FY2019 | Sep 29, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
See a number that looks wrong?